Production (Stage)
Kits Eyecare Ltd.
KTYCF
$9.96
$0.363.75%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.80% | 30.10% | 25.85% | 24.62% | 26.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.80% | 30.10% | 25.85% | 24.62% | 26.35% |
| Cost of Revenue | 27.42% | 30.50% | 26.62% | 23.14% | 24.33% |
| Gross Profit | 34.51% | 29.32% | 24.33% | 27.65% | 30.55% |
| SG&A Expenses | 22.76% | 22.06% | 19.12% | 17.28% | 15.83% |
| Depreciation & Amortization | -58.38% | -45.76% | -34.29% | -22.80% | -14.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.54% | 26.39% | 23.01% | 20.26% | 20.59% |
| Operating Income | 661.18% | 286.08% | 125.66% | 91.74% | 82.64% |
| Income Before Tax | 522.86% | 249.32% | 100.81% | 107.33% | 64.42% |
| Income Tax Expenses | 606.38% | 292.08% | 121.55% | 109.07% | 57.51% |
| Earnings from Continuing Operations | 494.65% | 236.31% | 96.52% | 106.86% | 66.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 494.65% | 236.31% | 96.52% | 106.86% | 66.29% |
| EBIT | 661.18% | 286.08% | 125.66% | 91.74% | 82.64% |
| EBITDA | 371.70% | 287.78% | 769.37% | 231.68% | 156.00% |
| EPS Basic | 490.64% | 235.44% | 96.30% | 107.03% | 64.87% |
| Normalized Basic EPS | 519.28% | 248.36% | 100.75% | 107.55% | 63.20% |
| EPS Diluted | 377.81% | 207.38% | 92.34% | 98.27% | 55.67% |
| Normalized Diluted EPS | 482.10% | 236.66% | 99.44% | 106.01% | 62.21% |
| Average Basic Shares Outstanding | 0.65% | 0.39% | -2.23% | -2.27% | -2.33% |
| Average Diluted Shares Outstanding | 4.37% | 5.92% | 1.45% | 2.48% | 0.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |